Pharmacokinetics, safety, and tolerability of a new patritumab formulation in patients with advanced, refractory solid tumors.

被引：4
作者：
Papadopoulos, Kyriakos P.
Moore, Kathleen N.
Lush, Richard
Desai, Madhuri
Mahmood, Syed
Beckman, Robert A.
Mendell-Harary, Jeanne
机构：
[1] START South Texas Accelerated Res Therapeut LLC, San Antonio, TX USA
[2] Peggy & Charles Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA
[3] H Lee Moffitt Canc Ctr & Res Inst Inc, Tampa, FL USA
[4] Daiichi Sankyo, Edison, NJ USA
[5] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e14026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14026
引用
收藏
页数：1
相关论文
共 50 条
[11]   POPULATION PHARMACOKINETICS OF GLASDEGIB IN PATIENTS WITH ADVANCED HEMATOLOGIC AND SOLID TUMORS. [J].
Lin, S. ;
Shaik, M. ;
Ruiz, A. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 :S78-S78
[12]   Safety, tolerability and pharmacokinetics of oral administration of GW786034 in pts with solid tumors. [J].
Hurwitz, H ;
Dowlati, A ;
Savage, S ;
Fernando, N ;
Lasalvia, S ;
Whitehead, B ;
Suttle, B ;
Collins, D ;
Ho, P ;
Pandite, L .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :195S-195S
[13]   Safety and tolerability of the olaparib tablet formulation in Japanese patients (pts) with advanced solid tumors (ASTs) [J].
Takahashi, Yasuo ;
Fujikawa, Koshi ;
Sagawa, Tamotsu ;
Yonemori, Kan ;
Tamura, Kenji ;
Kodaira, Makoto ;
Esaki, Taito ;
Shirakawa, Tsuyoshi ;
Hirai, Fumihiko ;
Yokoi, Yuki ;
Kawata, Toshio ;
Hatano, Ben .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[14]   Phase I safety and tolerability of once daily oral afatinib (A) in combination with docetaxel (D) in patients (pts) with relapsed or refractory advanced solid tumors. [J].
Senellart, Helene ;
Bennouna, Jaafar ;
Isambert, Nicolas ;
De-Montserrat, Helene ;
Squiban, Patrick J. ;
Tschoepe, Inga ;
Delord, Jean-Pierre .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[15]   Safety and pharmacokinetics of intravenous VEGF Trap in a phase I clinical trial of patients with advanced solid tumors. [J].
Dupont, J ;
Rothenberg, ML ;
Spriggs, DR ;
Cedarbaum, JM ;
Furfine, ES ;
Cohen, DP ;
Dancy, I ;
Lee, HS ;
Cooper, W ;
Lockhart, AC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :199S-199S
[16]   A phase I study of safety and pharmacokinetics of NanoBB-1-Dox in patients with advanced solid tumors. [J].
Filon, Olga ;
Krivorotko, Petr ;
Kobyakov, Grigory ;
Razjivina, Viktoria ;
Maximenko, Olga ;
Gelperina, Svetlana ;
Kreuter, Joerg .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[17]   Phase I trial to assess the safety and pharmacokinetics of afatinib and weekly vinorelbine in patients with advanced solid tumors. [J].
Hollebecque, Antoine ;
Bahleda, Rastislav ;
Berge, Yann ;
Massard, Christophe ;
Uttenreuther-Fischer, Martina Maria ;
De-Montserrat, Helene ;
Tschoepe, Inga ;
Soria, Jean-Charles ;
Delord, Jean-Pierre .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[18]   Safety, dose tolerance, pharmacokinetics and pharmacodynamics study of CPX-POM in patients with advanced solid tumors. [J].
Weir, Scott James ;
Wood, Robyn ;
Ham, Tammy ;
Challenger, Rashida ;
Ramamoorthy, Prabhu ;
Reed, Greg ;
Baltezor, Michael Jay ;
Jensen, Roy A. ;
Taylor, John Arthur ;
Anant, Shrikant ;
Dalton, Michael ;
McKenna, Michael J. ;
Zhukova-Harrill, Valentina ;
McCulloch, William ;
Burris, Howard A. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[19]   A phase I clinical study to evaluate the safety, tolerability, pharmacokinetics (PK), and antitumor activity of FN-1501 monotherapy in patients with advanced solid tumors. [J].
Richardson, Gary Edward ;
Vaishampayan, Ulka N. ;
Lin, Lin ;
Bozon, Viviana ;
Hui, Ai-Min ;
Williamson, Stephen K. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[20]   Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors [J].
Toshihiko Doi ;
Atsushi Ohtsu ;
Makoto Tahara ;
Tomohide Tamura ;
Kuniaki Shirao ;
Yasuhide Yamada ;
Satoru Otani ;
Bing-Bing Yang ;
Masayuki Ohkura ;
Tomoko Ohtsu .
International Journal of Clinical Oncology, 2009, 14 :307-314
12345